New Results
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines
Xiaoying Shen, Haili Tang, Charlene McDanal, Kshitij Wagh, Will Fischer, James Theiler, Hyejin Yoon, Barton F. Haynes, Kevin O. Sanders, Sandrasegaram Gnanakaran, Nick Hengartner, Rolando Pajon, Gale Smith, Filip Dubovsky, Gregory M. Glenn, Bette Korber, David C. Montefiori
doi: https://doi.org/10.1101/2021.01.27.428516
Xiaoying Shen
1Department of Surgery, Duke University School of Medicine, Durham, NC, USA
2Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA
Haili Tang
1Department of Surgery, Duke University School of Medicine, Durham, NC, USA
Charlene McDanal
1Department of Surgery, Duke University School of Medicine, Durham, NC, USA
Kshitij Wagh
3Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM USA
Will Fischer
3Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM USA
James Theiler
3Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM USA
Hyejin Yoon
3Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM USA
Barton F. Haynes
2Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA
6Department of Medicine, Duke University Medical Center, Durham, NC, USA
Kevin O. Sanders
1Department of Surgery, Duke University School of Medicine, Durham, NC, USA
2Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA
6Department of Medicine, Duke University Medical Center, Durham, NC, USA
Sandrasegaram Gnanakaran
3Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM USA
Nick Hengartner
3Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM USA
Rolando Pajon
4Moderna Inc., Cambridge, MA, USA
Gale Smith
5Novavax, Inc., Gaithersburg, MD, USA
Filip Dubovsky
5Novavax, Inc., Gaithersburg, MD, USA
Gregory M. Glenn
5Novavax, Inc., Gaithersburg, MD, USA
Bette Korber
3Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM USA
David C. Montefiori
1Department of Surgery, Duke University School of Medicine, Durham, NC, USA
2Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, USA
Article usage
Posted January 28, 2021.
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines
Xiaoying Shen, Haili Tang, Charlene McDanal, Kshitij Wagh, Will Fischer, James Theiler, Hyejin Yoon, Barton F. Haynes, Kevin O. Sanders, Sandrasegaram Gnanakaran, Nick Hengartner, Rolando Pajon, Gale Smith, Filip Dubovsky, Gregory M. Glenn, Bette Korber, David C. Montefiori
bioRxiv 2021.01.27.428516; doi: https://doi.org/10.1101/2021.01.27.428516
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines
Xiaoying Shen, Haili Tang, Charlene McDanal, Kshitij Wagh, Will Fischer, James Theiler, Hyejin Yoon, Barton F. Haynes, Kevin O. Sanders, Sandrasegaram Gnanakaran, Nick Hengartner, Rolando Pajon, Gale Smith, Filip Dubovsky, Gregory M. Glenn, Bette Korber, David C. Montefiori
bioRxiv 2021.01.27.428516; doi: https://doi.org/10.1101/2021.01.27.428516
Subject Area
Subject Areas
- Biochemistry (11745)
- Bioengineering (8752)
- Bioinformatics (29200)
- Biophysics (14972)
- Cancer Biology (12096)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18308)
- Genetics (12245)
- Genomics (16803)
- Immunology (11869)
- Microbiology (28085)
- Molecular Biology (11592)
- Neuroscience (60969)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7340)
- Zoology (1651)